Multicenter Pharmacokinetic Study of Pembrolizumab for Non-Small Cell Lung Cancer in Older Adults Aged Over 75 Years

被引：0
|
作者：
Horinouchi, H. [1 ]
Ohe, Y. [1 ]
Yamanaka, Y. [2 ]
Kurata, T. [2 ]
Watanabe, K. [3 ]
Hosomi, Y. [3 ]
Nakahara, Y. [4 ]
Asao, T. [5 ]
Saeki, S. [6 ]
Tsubata, Y. [7 ]
Fujita, Y. [8 ]
Konishi, J. S. [9 ]
Mizugaki, H. [10 ]
Ohuchi, M. [11 ]
Yagishita, S. [11 ]
Hamada, A. [11 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Kansai Med Univ Hosp, Osaka, Japan
[3] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[4] Kitasato Univ, Sch Med, Sagamihara, Kanagawa, Japan
[5] Juntendo Univ Hosp, Tokyo, Japan
[6] Kumamoto Univ Hosp, Kumamoto, Japan
[7] Shimane Univ, Fac Med, Matsue, Shimane, Japan
[8] Jikei Univ, Sch Med, Tokyo, Japan
[9] Hokkaido Univ, Fac Med, Sapporo, Hokkaido, Japan
[10] JFCR, Canc Inst Hosp, Tokyo, Japan
[11] Natl Canc Ctr, Res Inst, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Pembrolizumab; pharmacokinetics; Elderly;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-08
引用
收藏
页码：S622 / S622
页数：1
相关论文
共 50 条
  • [1] MULTICENTER PHARMACOKINETIC STUDY OF PEMBROLIZUMAB FOR NON-SMALL CELL LUNG CANCER IN OLDER ADULTS AGED OVER 75 YEARS
    Asao, T.
    Yamanaka, Y.
    Kurata, T.
    Watanabe, K.
    Hosomi, Y.
    Horinouchi, H.
    Ohe, Y.
    Nakahara, Y.
    Saeki, S.
    Tsubata, Y.
    Fujita, Y.
    Sakakibara--Konishi, J.
    Mizugaki, H.
    Ouchi, M.
    Yagishita, S.
    Hamada, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S57 - S57
  • [2] Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in older adults aged over 75 years
    Nakahara, Yoshiro
    Watanabe, Kageaki
    Hosomi, Yukio
    Yamanaka, Yuta
    Kurata, Takayasu
    Horinouchi, Hidehito
    Ohe, Yuichiro
    Asao, Tetsuhiko
    Saeki, Sho
    Tsubata, Yukari
    Fujita, Yu
    Konishi, Jun Sakakibara
    Mizugaki, Hidenori
    Ohuchi, Mayu
    Yagishita, Shigehiro
    Hamada, Akinobu
    CANCER RESEARCH, 2023, 83 (07)
  • [3] Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in older adults aged over 75 years
    Saeki, Sho
    Yamanaka, Yuta
    Kurata, Takayasu
    Watanabe, Kageaki
    Hosomi, Yukio
    Horinouchi, Hidehito
    Ohe, Yuichiro
    Nakahara, Yoshiro
    Asao, Tetsuhiko
    Tsubata, Yukari
    Fujita, Yu
    Konishi, Jun Sakakibara
    Mizugaki, Hidenori
    Ohuchi, Mayu
    Yagishita, Shigehiro
    Hamada, Akinobu
    ANNALS OF ONCOLOGY, 2023, 34 : S1395 - S1395
  • [4] Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in adults aged older than 75 years
    Yamanaka, Yuta
    Kurata, Takayasu
    Watanabe, Kageaki
    Hosomi, Yukio
    Horinouchi, Hidehito
    Ohe, Yuichiro
    Nakahara, Yoshiro
    Asao, Tetsuhiko
    Saeki, Sho
    Tsubata, Yukari
    Fujita, Yu
    Sakakibara-Konishi, Jun
    Mizugaki, Hidenori
    Ouchi, Mayu
    Yagishita, Shigehiro
    Hamada, Akinobu
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Multicenter pharmacokinetic study of pembrolizumab for non-small cell lung cancer in elderly adults aged over 75
    Sakakibara-Konishi, J.
    Yamanaka, Y.
    Kurata, T.
    Watanabe, K.
    Hosomi, Y.
    Horinouchi, H.
    Ohe, Y.
    Nakahara, Y.
    Asao, T.
    Saeki, S.
    Tsubata, Y.
    Fujita, Y.
    Mizugaki, H.
    Ohuchi, M.
    Yagishita, S.
    Hamada, A.
    ANNALS OF ONCOLOGY, 2023, 34
  • [6] Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older
    Yagishita, Shigehiro
    Yamanaka, Yuta
    Kurata, Takayasu
    Watanabe, Kageaki
    Hosomi, Yukio
    Horinouchi, Hidehito
    Ohe, Yuichiro
    Nakahara, Yoshiro
    Naoki, Katsuhiko
    Asao, Tetsuhiko
    Takahashi, Kazuhisa
    Saeki, Sho
    Sakagami, Takuro
    Nakashima, Kazuhisa
    Tsubata, Yukari
    Fujita, Yu
    Wakui, Hiroshi
    Furuta, Megumi
    Konishi, Jun Sakakibara
    Ohuchi, Mayu
    Ando, Yuichi
    Mizugaki, Hidenori
    Hamada, Akinobu
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 116 (04) : 1042 - 1051
  • [7] Stage IV non-small cell lung cancer patients aged 75 years and older
    Tamura, T.
    Kurishima, K.
    Watanabe, H.
    Nakazawa, K.
    Ishikawa, H.
    Satoh, H.
    Hizawa, N.
    EUROPEAN GERIATRIC MEDICINE, 2015, 6 (01) : 31 - 35
  • [8] Non-small cell lung cancer in patients aged 75 years and older: A community-based experience
    Reddy, S. K.
    Berdan, M.
    Curti, M.
    Janis, M.
    Minow, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Efficacy and Safety of First-Line Pembrolizumab Monotherapy in Elderly Patients (Aged ≥ 75 years) with Non-Small Cell Lung Cancer
    Sugiyama, T.
    Imai, H.
    Wasamoto, S.
    Yamaguchi, O.
    Suzuki, K.
    Uchino, J.
    Minemura, H.
    Osaki, T.
    Ishii, T.
    Umeda, Y.
    Taniguchi, H.
    Kasai, T.
    Minato, K.
    Kaira, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S453 - S453
  • [10] Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer
    Hisao Imai
    Satoshi Wasamoto
    Ou Yamaguchi
    Kensuke Suzuki
    Tomohide Sugiyama
    Junji Uchino
    Hiroyuki Minemura
    Takashi Osaki
    Hisashi Ishii
    Yukihiro Umeda
    Keita Mori
    Mie Kotake
    Hiroshi Kagamu
    Nobutoshi Morozumi
    Hirokazu Taniguchi
    Takashi Kasai
    Koichi Minato
    Kyoichi Kaira
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 457 - 466
12345